Abstract
The approach to cardiovascular (CVD) disease prevention is changing. The recommended procedures postulate increasingly ambitious target values, to achieve which we have a number of new treatment options available.
CV risk assessment remains the basis for the choice of treatment interventions. For this, we use the SCORE 2 and SCORE OP tables from 2021 for asymptomatic persons.
Although the new algorithms have made the risk estimate more accurate in marginal groups of patients, it is true that they can significantly underestimate the real long-term risk. In addition, the presentation of the chance of a vascular event in the order of individual percentages is often not a strong enough motivation for changing lifestyle or starting drug therapy.
Misunderstanding negatively affects the adherence of such patients. In addition to communicating long-term cardiovascular risk, we can use the concept of vascular age to improve patient acceptance.
This simplifies the explanation of the concept of risk and demonstrably increases the proportion of patients who adhere to treatment measures. Together with the promotion of the principles of rational pharmacotherapy with the maximum use of fixed combinations for the intervention of the main risk factors of CV disease, the procedures described above belong to the foundations of the strategy for improving the results of CV prevention.